Skip to main content
. 2015 Sep 2;19(7):1288–1295. doi: 10.1017/S136898001500244X

Table 1.

Sociodemographic characteristics of women participating in a randomized clinical trial (n 54)

Characteristic Mean sd
Age (years) 54·4 12·1
BMI (kg/m2) 27·3 5·6
Cruciferous vegetable intake (g/d)* 81·7 57·3
Total SFN ITC from urine (μm; n 43) 0·08 0·07
Total SFN ITC from plasma (μm; n 34) 0 0
n %
Race
White 40 74·07
Non-white/missing 14 25·93
Family history of breast cancer
Yes 20 37·04
No 34 62·96
Smoking
Current 2 3·70
Former 12 22·22
Never 32 59·26
Missing 8 14·81
Alcohol
Current 21 38·89
Former 6 11·11
Never 18 33·33
Missing 9 16·67
Income
≤$US 25 000 12 22·22
$US 25 000–50 000 4 7·41
>$US 50 000 25 46·30
Refuse/don’t know/missing 13 24·07
Education
≤12 years 6 11·11
Some college/technical 11 20·37
≥College graduate 26 48·15
Missing 11 20·37
Marital status
Single, divorced, widowed 18 33·33
Married/partner 27 50·00
Missing 9 16·67
Use of NSAID
Yes 28 51·85
No 25 46·30
Missing 1 1·85
Menopausal status
Pre 19 35·19
Peri 12 22·22
Post 23 42·59
Pathology biopsy diagnosis
No cancer 24 44·40
Hyperplasia 4 7·41
DCIS or DCIS+ADH 17 31·48
Invasive cancer with DCIS or DCIS+ADH 9 16·67

SFN ITC, sulforaphane isothiocyanates; NSAID, non-steroidal anti-inflammatory drugs; DCIS, ductal carcinoma in situ; ADH, atypical ductal hyperplasia.

*

Cruciferous vegetable intake includes sources from food lines, mixed dishes and condiments.

For the thirteen women who did not report their menopausal status, those aged <45 years were grouped into premenopausal status, those aged 45–55 years were grouped into perimenopausal status and those aged >55 years were grouped into postmenopausal status.

Percentages may not add up to 100 due to rounding.